Beihai Gofar Chuanshan Biological Co., Ltd. Share Price
Equities
600538
CNE000001DD2
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.63 CNY | -0.22% | -4.14% | -0.22% |
Sales 2022 | 460M 63.48M 5.06B | Sales 2023 | 369M 50.98M 4.06B | Capitalization | 2.43B 336M 26.77B |
---|---|---|---|---|---|
Net income 2022 | 34M 4.7M 374M | Net income 2023 | -82M -11.32M -902M | EV / Sales 2022 | 4.81 x |
Net cash position 2022 | 156M 21.59M 1.72B | Net cash position 2023 | 139M 19.26M 1.53B | EV / Sales 2023 | 6.21 x |
P/E ratio 2022 |
64.6
x | P/E ratio 2023 |
-29
x | Employees | 501 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 66.14% |
1 day | -0.22% | ||
1 week | -4.14% | ||
Current month | -2.94% | ||
1 month | -2.94% | ||
3 months | +0.43% | ||
6 months | +6.93% | ||
Current year | -0.22% |
Managers | Title | Age | Since |
---|---|---|---|
Li Bin Pan
CEO | Chief Executive Officer | 60 | 24/09/09 |
Zhi Bo Yin
DFI | Director of Finance/CFO | 57 | 17/05/10 |
Yong Li
BRD | Director/Board Member | 59 | 31/12/00 |
Members of the board | Title | Age | Since |
---|---|---|---|
Zhi Bo Yin
DFI | Director of Finance/CFO | 57 | 17/05/10 |
Li Bin Pan
CEO | Chief Executive Officer | 60 | 24/09/09 |
Tao Peng
BRD | Director/Board Member | 52 | 16/05/21 |
Date | Price | Change | Volume |
---|---|---|---|
29/04/24 | 4.63 | -0.22% | 6,122,520 |
26/04/24 | 4.64 | -3.33% | 6,425,500 |
25/04/24 | 4.8 | -1.44% | 9,943,700 |
24/04/24 | 4.87 | +0.62% | 12,329,080 |
23/04/24 | 4.84 | +0.21% | 5,442,982 |
End-of-day quote Shanghai S.E., April 28, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-0.22% | 336M | |
+15.79% | 71.39B | |
+2.09% | 25.1B | |
-1.96% | 8.59B | |
+7.95% | 8.19B | |
-20.48% | 7.91B | |
+15.26% | 4.31B | |
-1.24% | 3.93B | |
-3.02% | 3.86B | |
+21.10% | 3.64B |
- Stock Market
- Equities
- 600538 Stock